Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 2
2021 pubmed 21 citations

Efficacy of antimicrobial peptide LL-37 against biofilm forming Staphylococcus aureus strains obtained from chronic wound infections.

Demirci. Mehmet M; Yigin. Akin A; Demir. Cemil C

Key Findings

  • LL-37 inhibits MSSA at ~90 mg/L and MRSA at ~132 mg/L, which are relatively high concentrations
  • LL-37 reduces biofilm formation similarly in both MSSA and MRSA strains
  • At sub‑MIC levels, LL-37 alters expression of quorum‑sensing and biofilm genes (atlA, RNAIII, agrA)

Practical Outcomes

  • LL-37 shows promise for topical wound‑care products that target biofilms, but the required dose is too high for practical self‑administration. For now, it’s mainly useful as a research lead for developing peptide‑based dressings rather than a DIY supplement.

Summary

LL-37 can kill Staph bacteria from chronic wounds, but you need a lot of it (around 90‑130 mg/L) to do so. It also changes some genes that control biofilm and communication even at lower, non‑killing levels, which might help stop the sticky layers bacteria form. However, the amounts needed are high, so it’s not something you can easily use at home right now.

Abstract

The antimicrobial peptide LL-37 showed inhibitory effects against Staphylococcus aureus strains, which often responsible for wound infections. Understanding the molecular mechanisms of biofilm-containing wound infections is important. Thus, this study aimed to investigate both the antimicrobial and biofilm efficacy of LL-37 against biofilm-positive methicillin-susceptible S. aureus (MSSA) strains and biofilm-positive methicillin-resistant S. aureus (MRSA) strains obtained from chronic wound infections and its effect on different quorum sensing and virulence genes at suboptimal concentrations. Fifteen biofilm-forming MRSA and 15 biofilm-forming MSSA strains were included in this study. The minimum inhibitory concentration (MIC) values and biofilm formation were tested by microdilution methods. Real-time PCR was performed to determine gene expression levels. MIC values for LL-37 were 89.6 mg/L and 132.3 mg/L for MSSA and MRSA strains, respectively. No statistically significant difference was found between MRSA and MSSA strains in terms of the effect of LL-37 on biofilm formation. A statistically significant difference was found between MRSA and MSSA strains for atlA, RNAIII, and agrA gene expression levels following exposure to a suboptimal concentration of LL-37. Ultimately, the required LL-37 antimicrobial concentration was quite high; however, LL-37 antibiofilm concentration may be acceptable for use in humans against biofilm-forming MRSA and MSSA strains. This is the first study to investigate to effect of a suboptimal LL-37 concentration on gene expression levels of biofilm-forming MSSA and MRSA strains. LL-37 affected quorum sensing and biofilm producing mechanisms, even at suboptimal MIC concentrations.

Study Information

Provider

pubmed

Year

2021

Date

2021-12-20T00:00:00.000Z

DOI

10.1016/j.micpath.2021.105368

Citations

21